ARTICLE | Finance
BioCentury’s latest Venture Report includes rounds for Judo, Purespring, Basecamp, Arda and more
By Stephen Hansen, Director of Biopharma Intelligence
October 11, 2024 1:22 AM UTC
John Maraganore is getting back into RNAi, but this time as executive chair of newco City.
With $135 million raised in a series A round, the co-founder and former CEO of RNAi leader Alnylam Inc. (NASDAQ:ALNY) is looking to build the next generation of siRNA molecules at Cambridge, Mass.-based City Therapeutics Inc. The round was led by Arch Venture Partners, where Maraganore is also a venture partner…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/653846/city-is-location-of-maraganore-s-next-rnai-play